Commentary
Find our newspaper columns, blogs, and other commentary pieces in this section. Our research focuses on Advanced Biology, High-Tech Geopolitics, Strategic Studies, Indo-Pacific Studies & Economic Policy
Omicron: Is India testing enough?
By Mahek Nankani and Harshit Kukreja
With the onslaught of the third wave, low testing rates have become a point of concern. With positivity rates touching 30 per cent in some cities as against the World Health Organisation (WHO)’s recommended five per cent, we do not see a proportional rise in the number of cases. This low number contributes to the narrative about the meekness of the Omicron variant hindering our implementation of the 3T strategy of testing, tracking and treatment.
Omicron: Clinically milder but potentially deadlier
By Mahek Nankani and Harshit Kukreja
There has been a sudden surge in Covid cases across the country in the past few days. This increase can be attributed to the newest Covid-19 variant: Omicron. Ignorance, misconception, and a delay in response could result in India's even more fatal third wave. With India still reeling from the effects of earlier waves and the economic crisis, a new variant, while less fatal, could turn out to be deadlier.